Results 11 to 20 of about 11,654 (184)

The EHA Research Roadmap: Anemias [PDF]

open access: yesHemaSphere, 2021
Achille Iolascon1,2, Stefano Rivella3,4,5,6,7, Nicholas P. Anagnou8, Clara Camaschella9, Dorine Swinkels10, Martina U. Muckenthaler11, Graça Porto12, Wilma Barcellini13, Immacolata Andolfo1,2, Antonio M.
A. Iolascon   +18 more
semanticscholar   +10 more sources

The EHA Research Roadmap: Infections in Hematology [PDF]

open access: yesHemaSphere, 2021
Since the initial publication of the EHA Roadmap, major advances have been achieved in the management of infectious complications in the hematology ward.
C. Cordonnier   +13 more
semanticscholar   +7 more sources

The EHA Research Roadmap: Normal Hematopoiesis [PDF]

open access: yesHemaSphere, 2021
No description ...
Jaffredo, Thierry   +40 more
  +15 more sources

The EHA Research Roadmap: Malignant Myeloid Diseases [PDF]

open access: yesHemaSphere, 2021
In 2016, the European Hematology Association (EHA) published the EHA Roadmap for European Hematology Research1 aiming to highlight achievements in the diagnostics and treatment of blood disorders, and to better inform European policy makers and other stakeholders about the urgent clinical and scientific needs and priorities in the field of hematology ...
Dohner H.   +20 more
openaire   +9 more sources

Immune Effector Cell-Associated Hematotoxicity (ICAHT): EHA/EBMT Consensus Grading and Best Practice Recommendations.

open access: yesBlood, 2023
Hematological toxicity represents the most common adverse event following chimeric antigen receptor (CAR) T-cell therapy. Cytopenias can be profound, long-lasting, and can predispose for severe infectious complications.
K. Rejeski   +36 more
semanticscholar   +1 more source

Management of Adults and Children receiving CAR T-cell therapy: 2021 Best Practice Recommendations of the European Society for Blood and Marrow Transplantation (EBMT) and the Joint Accreditation Committee of ISCT and EBMT (JACIE) and the European Haematology Association (EHA).

open access: yesAnnals of Oncology, 2021
BACKGROUND Several commercial and academic autologous chimeric antigen receptor T-cell products targeting CD19 have been approved in Europe for relapsed/refractory B-cell acute lymphoblastic leukemia, high-grade B-cell lymphoma, and mantle cell lymphoma.
P. Hayden   +35 more
semanticscholar   +1 more source

The EHA Research Roadmap: Transfusion Medicine

open access: yesHemaSphere, 2022
In 2016, the European Hematology Association (EHA) published the EHA Roadmap for European Hematology Research 1 aiming to highlight achievements in the diagnostics and treatment of blood disorders, and to better inform European policy makers and other stakeholders about the urgent clinical and scientific needs and priorities in the field of hematology.
Stanworth, Simon   +22 more
openaire   +10 more sources

An International Survey on Grading, Diagnosis, and Management of Immune Effector Cell-Associated Hematotoxicity (ICAHT) Following CAR T-cell Therapy on Behalf of the EBMT and EHA

open access: yesHemaSphere, 2023
Hematological toxicity represents the most common grade ≥3 toxicity after chimeric antigen receptor (CAR) T-cell therapy. However, its underlying pathophysiology is incompletely understood and its grading and management remains ill-defined. To inform the
K. Rejeski   +8 more
semanticscholar   +1 more source

Electrical and Photodetector Characteristics of Schottky Structures Interlaid with P(EHA) and P(EHA-co-AA) Functional Polymers by the iCVD Method

open access: yesACS Omega, 2023
In this study, poly(2-ethylhexyl acrylate) (PEHA) homopolymer and its copolymer combined with acrylic acid P(EHA-co-AA) were employed as interfaces in two separate Schottky structures.
S. Demirezen   +5 more
semanticscholar   +1 more source

The EHA Research Roadmap: Platelet Disorders

open access: yesHemaSphere, 2021
In 2016, the European Hematology Association (EHA) published the EHA Roadmap for European Hematology Research1 aiming to highlight achievements in the diagnostics and treatment of blood disorders, and to better inform European policy makers and other stakeholders about the urgent clinical and scientific needs and priorities in the field of hematology ...
Balduini, Carlo   +22 more
openaire   +7 more sources

Home - About - Disclaimer - Privacy